Loading...

Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53

BACKGROUND: The majority of ovarian cancer cases are diagnosed at an advanced stage with poor prognosis. This study evaluates autoantibodies against tumor antigens to identify candidate biomarkers for early detection of ovarian cancer in women at increased risk. OBJECTIVE: To assess the immunoreacti...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Biomark
Main Authors: Hurley, Laura C., Levin, Nancy K., Chatterjee, Madhumita, Coles, Jasmine, Muszkat, Shlomo, Howarth, Zachary, Dyson, Gregory, Tainsky, Michael A.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8076913/
https://ncbi.nlm.nih.gov/pubmed/32083570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/CBM-190988
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!